Photo: Franck Gazzola/Rolex
Photo: Franck Gazzola/Rolex - WearOptimo's life-saving Microwearable sensor technology heads into production, with $30 million deal. A revolutionary healthcare technology with potential to save millions of lives globally is poised to enter mass-production following the announcement of a $30 million deal in Australia. The project will fund an advanced technology facility in Brisbane, Australia - a critical step to WearOptimo making and distributing its MicrowearableTM sensor health technology worldwide. WearOptimo's inexpensive, pain-free wearable devices can give patients and their doctors early warning of life-threatening events such as heart attacks, heat stroke and other conditions. They represent a breakthrough in personalised medicine. A partnership between the Queensland Government, The Australian National University (ANU), WearOptimo, and the Australian National Fabrication Facility (ANFF) will invest $30 million in a globally-competitive, high-tech manufacturing facility - based in Australia - for production of Microwearable sensors to reach into key healthcare markets. WearOptimo's "sticker-like" Microwearable sensors provide real-time monitoring and fast, accurate reports on a patient's health to enable timely medical care.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.